Dr. Brett Michael Morrison, MD, PhD

Dr. Morrison practices at Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland.

Dr. Morrison's NPI, 1518090752, was assigned on March 14, 2007. Dr. Morrison graduated from Icahn School of Medicine at Mount Sinai in 2001. Dr. Morrison holds Maryland license D0063969.

Dr. Morrison's primary practice is Johns Hopkins Hospital Nelson/Harvey Building, at 600 N Wolfe St, Baltimore, MD 21287 in Baltimore City. The practice phone is (855) 662-3017.

Dr. Morrison's primary practice is Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland. Dr. Morrison is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Morrison to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Morrison practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Morrison's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Morrison is licensed in Maryland.

CMS data shows 535 Medicare services from Dr. Morrison across 9 procedure codes in 2024, for 287 Medicare patients. Medicare paid $35,090 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 287 Medicare patients who saw Dr. Morrison in 2024. The largest group is 65 to 74, with 125 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Morrison's median patient age at 71, with 46% women.

In 2024, Dr. Morrison wrote 274 Medicare Part D claims for 53 patients. 83% of them were for generic drugs. CMS names the drug for 224 of them, across 8 drugs with 11 or more claims each, at $743,665 in total drug cost. In 2023, CMS named 145 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Morrison for performance year 2024, reported as part of a group. CMS lists Dr. Morrison as offering telehealth.

Dmand AI links 18 papers to Dr. Morrison, published from 2012 to 2024. 2020 was the busiest year, with 4. The most frequent topics are Monocarboxylic Acid Transporters, Symporters and Lactic Acid. Dr. Morrison has published most often in Exp Neurol. Dr. Morrison's most frequent co-authors are Jeffrey Rothstein, MD, Ahmet Hoke, MD and Michael James Polydefkis, MD.

CMS Open Payments shows 16 general payments to Dr. Morrison from 3 drug and device companies from 2024 to 2025. Consulting fees make up the largest share, 72% of the total. Pfizer Inc. paid the most, $5,000.

Dr. Morrison graduated from Icahn School of Medicine at Mount Sinai in 2001.